DESIGN AND DEVELOPMENT OF POTENTIAL ANTI-TUBERCULAR LEADS POSSESSING 4-AMINO QUINOLINE MOIETY AS DNA GYRASE B INHIBITORS Authors: Venkatesan S , PAVITHRA L#, HARITHA M, APARNA RAM, GOPINATH P AND KATHIRAVAN MK*
ABSTRACT
DNA gyrase B subunit, a druggable target of potent anti-tubercular agents is involved in the process
of ATP hydrolysis which in turn provides energy to gyrase A subunit for maintaining the DNA
topological state. In the present study, we employed structural optimization of the reported Gyrase B
inhibitors possessing quinoline nucleus employing Quantitative Structure-Activity Relationship
(QSAR) and docking studies. QSAR studies were carried out by QSARINS software on 4-
aminoquinoline derivatives for the best model having four variables L1i, MoRSEN26, RDFM5 and
RDFE25 with statistical values R2 = 0.7430, LOF=0.0608, CCCtr = 0.8525, Q2LOO = 0.6461,
Q2LMO = 0.6189, CCCcv = 0.7972, R2ext = 0.8294, and CCCext = 0.8898. The developed QSAR
model suggests that the 3D-Weighted Holistic Invariant Molecular descriptors (3D-WHIM), 3D-
Molecular representations of structure based on electron diffraction descriptors (3D-MoRSE) and
Radial Distribution Function (RDF) descriptors play key roles in predicting bioactivity. The designed
compounds using QSAR model predicted molecular descriptor information yielded compounds 42a
and 42c as good potential theoretical candidates. Binding energy scores of the designed compounds
provided nanomolar activity binding interactions in the active site of 3zkd: DNA Gyrase B enzyme.
Compound 42a, with predicted activity of ~80nM MIC will be take over for further experimental
studies as anti-tubercular lead.
Keywords: Anti-mycobacterial activity, Autodock, MoRSE, QSAR Publication date: 01/04/2023 https://ijbpas.com/pdf/2023/April/MS_IJBPAS_2023_6883.pdfDownload PDFhttps://doi.org/10.31032/IJBPAS/2023/12.4.6883